Clinical trial
Usefulness of Selegiline as an Aid to Quit Smoking - 1
NCT00129311 · Yale University, Other · Completed
Key facts
| NCT number | NCT00129311 |
|---|---|
| Title | Usefulness of Selegiline as an Aid to Quit Smoking - 1 |
| Official title | Usefulness of Selegiline for Smoking Cessation |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tobacco Use Cessation |
| Intervention type | Drug |
| Interventions | Selegiline, Placebo |
| Enrollment | 101 |
| Start date | Jul 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Aug 11, 2005 |
| Last update posted | Mar 31, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: